FIELD: chemistry.
SUBSTANCE: present invention relates to a method for the production of essentially diastereomeric pure phosphorodiamidate morpholino-oligomer containing chiral phosphoric bonds, which is used for the production of stereo-chemically pure oligonucleotide. The proposed method includes following stages: selection of essentially stereo-chemically pure phosphoramidochloride morpholino-monomers; and synthesis of essentially diastereomeric pure phosphorodiamidate morpholino-oligomer by stereo-specific combination of selected essentially stereo-chemically pure phosphoramidochloride morpholino-monomers, where the specified stereo-specific combination is carried out in an aprotic solvent in the presence of non-nucleophilic tertiary amine or aromatic base, at a temperature from 20°C to 50°C. At the same time, essentially stereo-chemically pure phosphoramidochloride morpholino-monomers are obtained by separation of a diastereomeric mixture of phosphoramidochloride morpholino-monomers into essentially stereo-chemically pure phosphoramidochloride morpholino-monomers. Essentially stereo-chemically pure, in this case, relates to enantiomers or diastereomers, which are in enantiomeric or diastereomeric excess, respectively, equal to or more than 87%, and essentially diastereomeric pure relates to diastereomers, which are in diastereomeric excess equal to or more than 87%.
EFFECT: obtainment of a method for the production of oligomers.
6 cl, 11 dwg, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
NEW QUINOLINE COMPOUNDS | 2018 |
|
RU2810113C2 |
NEW COMPOUNDS - NEUROKININ 1 RECEPTOR ANTAGONIZER | 2013 |
|
RU2631319C2 |
MACROCYCLIC HEPATITIS C VIRUS INIHBITORS | 2006 |
|
RU2437886C2 |
ATROPOISOMERS OF 3-SUBSTITUTED-4-ARYLQUINOLINE-2-ON DERIVATIVES | 2003 |
|
RU2352563C2 |
2-PYRIDONE DERIVATIVES | 2010 |
|
RU2551847C2 |
COMPOUNDS | 2016 |
|
RU2725616C2 |
METHOD OF OBTAINING 5-BIPHENYL-4-AMINO-2-METHYLPENTANOIC ACID | 2008 |
|
RU2530900C2 |
ENANTIOMERICALLY PURE BASIC ARYLCYCLOALKYLHYDROXYCARBOXYLIC ACID ESTERS, METHOD FOR THEIR PREPARING AND APPLYING IN MEDICINAL AGENTS | 1997 |
|
RU2238936C2 |
IMIDAZOTRIAZINONE COMPOUNDS | 2011 |
|
RU2603140C2 |
MACROCYCLIC HEPATITIS TYPE C VIRUS INHIBITORS | 2006 |
|
RU2419619C2 |
Authors
Dates
2023-03-09—Published
2016-08-05—Filed